Clinical trials
Terminated Thyroid Cancer, Papillary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2014 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AHS Cancer Control Alberta | 1 |
| Aminex Therapeutics, Inc. | 1 |
| Day One Biopharmaceuticals, Inc. | 1 |
| Emory University | 1 |
| Grupo Espanol de Tumores Neuroendocrinos | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Hoffmann-La Roche | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mayo Clinic | 1 |
| Nantes University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thyroid Cancer, Papillary | 13 |
| Adenocarcinoma, Follicular | 6 |
| Thyroid Neoplasms | 6 |
| Colorectal Neoplasms | 3 |
| Head and Neck Neoplasms | 3 |
| Melanoma | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Medullary | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplasms | 2 |
Trials
Showing 51 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.